Blog
Notes on contract manufacturing, regulation and export from the factory floor in Sadat City.
Egypt's dietary supplement manufacturing base grew nearly sixfold in five years. A look at what drove it, what the NFSA White List actually requires, and what it means if you are sourcing a contract manufacturer.
The real sequence a supplement contract manufacturer runs — formulation review, trial batches, registration, production and release — and which stages hold your timeline.
Not the certificate on the wall — the weight checks, the visual sort, the in-process lab and the EGP 80,000 monthly alcohol bill. A concrete look at what quality costs and what it catches.
Tablets, capsules, sachets, effervescents, liquids and jars — what each format does well, what it costs you, and the questions that actually decide the choice.
What Egypt's National Food Safety Authority White List actually certifies, how a factory gets listed, and the four things buyers wrongly assume a listing covers.
Egypt gives an exporter geography, cost and duty-free access across Arab and African markets. What it does not give you is a single registration path — and that, not manufacturing, is where export timelines are won or lost.
Private label, white label, contract manufacturing, toll manufacturing, OEM and co-manufacturing are not synonyms. What each commits you to, when each fits, and why Egyptian law rules out the invisible manufacturer.
Organix states 45 to 90 days for delivery. Here is what each stage before and after that window actually costs you, which stage is the longest, and why our chairman has publicly apologised for delays.
A certificate of analysis is a claim, not a measurement. What a supplement factory tests on every incoming raw material, the four ways an ingredient supply chain goes wrong, and what should happen when a lot fails.
Packaging is a cost, a timeline risk and a shelf decision, usually decided last and usually the reason a launch slips. Primary versus secondary, moisture barriers, artwork, and the Egyptian label rule that changes artwork planning.
What actually happens in formula development: the manufacturability question that comes before any price, why overages exist, what excipients are for, and the four very different things brand owners mean by "a formula".
Class D is the lowest pharmaceutical clean-room grade, which misleads people. What the classification measures, what it adds over a general food GMP, and why cross-contamination control matters most in a plant making for hundreds of brands.
French companies withdrew from West Africa and left shelf space behind them. Why Egyptian manufacturing fits Senegal, Niger and Nigeria, how registration differs between the two language blocs, and the risks nobody prices in.
Egyptian law puts the manufacturing facility's name on every pack it makes. What that does to a brand owner's supplier choice, how to use it as due diligence, and how it differs from markets where the manufacturer stays invisible.
A young authority, two separate clearances, more than 12,000 registered notifications and a decree that nearly stopped the sector. What a foreign brand owner should expect from the Egyptian regulatory process, stage by stage.
A buyer's audit guide for any contract manufacturer: what to request before you travel, how to walk the material flow, the four record pulls that reveal the truth, and the red flags worth walking away from.
Organix has opened a dedicated effervescent department for tablets and powder sachets. What that capability actually requires: humidity engineering, dry granulation, moisture-barrier packs, and two separate production routes.
Liquids were this factory's first capability. What the format actually buys you — dose adjustable by volume — and what it costs: microbiological risk, fill accuracy, suspension stability, shorter shelf life and freight on water.
Organix packs honey, extra-virgin olive oil, cocoa and drink powders and liquid chocolate alongside supplements. What food work demands that supplement manufacturing does not, and why the overlap is useful.
Organix was started by a pharmaceutical marketer with no manufacturing background, through an industrial-plot programme. The sequence, the regulatory groundwork, the hiring problem, and why quality got veto power.
